Evidence map›Paper›PMID 39909380›Full record

ArticleThe Journal of biological chemistry2025

Topology-driven discovery of transmembrane protein S-palmitoylation.

Michael T Forrester, Jacob R Egol, Sinan Ozbay, Farrah D Waddell, Rohit Singh, Purushothama Rao Tata

Abstract readDataset
In one paragraph

Article in The Journal of biological chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Biochemistry · 2026
    Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Michael T ForresterDivision of Pulmonary, Allergy and Critical Care Medicine, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: michael.forrester@duke.edu.
Jacob R EgolDepartment of Cell Biology, Duke University School of Medicine, Durham, North Carolina, USA.
Sinan OzbayDepartment of Cell Biology, Duke University School of Medicine, Durham, North Carolina, USA.
Farrah D WaddellDepartment of Cell Biology, Duke University School of Medicine, Durham, North Carolina, USA.
Rohit SinghDepartment of Cell Biology, Duke University School of Medicine, Durham, North Carolina, USA.
Purushothama Rao TataDivision of Pulmonary, Allergy and Critical Care Medicine, Duke University School of Medicine, Durham, North Carolina, USA; Department of Cell Biology, Duke University School of Medicine, Durham, North Carolina, USA; Duke Regeneration Center, Duke University School of Medicine, Durham, North Carolina, USA.

Funding

Molecular control of a novel transitional cell state in alveolar regenerationR01HL153375 · NHLBI · DUKE UNIVERSITY · PI Purushothama Rao Tata · 2020 to 2026
$3.4M
Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)T32HL160494 · NHLBI · DUKE UNIVERSITY · PI Jennifer L. Ingram, DAVID MARTIN MURDOCH · 2022 to 2026
$2.6M
Cellular crosstalk and molecular mechanisms in the initiation and progression of pulmonary fibrosisR01HL160939 · NHLBI · DUKE UNIVERSITY · PI TATA, PURUSHOTHAMA RAO · 2022 to 2025
$2.1M
NHLBI NIH HHS R01 HL153375NHLBI NIH HHS R01 HL160939NHLBI NIH HHS T32 HL160494
6 · The paper itself

Abstract

Protein S-palmitoylation is a reversible lipophilic posttranslational modification regulating diverse signaling pathways. Within transmembrane proteins (TMPs), S-palmitoylation is implicated in conditions from inflammatory disorders to respiratory viral infections. Many small-scale experiments have observed S-palmitoylation at juxtamembrane Cys residues. However, most large-scale S-palmitoyl discovery efforts rely on trypsin-based proteomics within which hydrophobic juxtamembrane regions are likely underrepresented. Machine learning-by virtue of its freedom from experimental constraints-is particularly well suited to address this discovery gap surrounding TMP S-palmitoylation. Utilizing a UniProt-derived feature set, a gradient-boosted machine learning tool (TopoPalmTree) was constructed and applied to a holdout dataset of viral S-palmitoylated proteins. Upon application to the mouse TMP proteome, 1591 putative S-palmitoyl sites (i.e. not listed in SwissPalm or UniProt) were identified. Two lung-expressed S-palmitoyl candidates (synaptobrevin Vamp5 and water channel Aquaporin-5) were experimentally assessed, as were three Type I transmembrane proteins (Cadm4, Chodl, and Havcr2). Finally, TopoPalmTree was used for the rational design of an S-palmitoyl site on KDEL-Receptor 2. This readily interpretable model aligns the innumerable small-scale experiments observing juxtamembrane S-palmitoylation into a proteomic tool for TMP S-palmitoyl discovery and design, thus facilitating future investigations of this important modification.

Indexed as

LipoylationMembrane ProteinsAnimalsCytoplasmDatabases, ProteinHEK293 CellsHumansHydrophobic and Hydrophilic InteractionsMachine LearningMiceProteomeMembrane ProteinsProteomegradient boostingmachine learningS-acylationS-palmitoylationtransmembrane protein

Identifiers

PMID39909380
PMCPMC11923826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.